Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing
Glooko, Inc. and Hedia, today announced the launch of their interoperable solution, which combines connected care, remote ...
GlobalData on MSN16h
Glooko and Hedia launch joint diabetes management solution
Glooko’s integration of Hedia’s diabetes tech aims to improve care for patients and enhance healthcare provider insights.
Tandem Diabetes price target raised to $44 from $42 at Bernstein
Bernstein analyst Lee Hambright raised the firm’s price target on Tandem Diabetes (TNDM) to $44 from $42 and keeps an Outperform rating on the ...
Taiwan News3d
Vietnam Insulin Pumps Market With Complete SWOT Analysis by Forecast From 2025 to 2033
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Insulin Pumps Market offers comprehensive insights into the market landscape, customer intelligence, ...
Research advances in developing fully automated insulin delivery
This research and delivery system will help patients with type 1 and type 2 diabetes receive their insulin based on real-time glucose levels.
10 Best Diabetes Stocks To Buy Under $10
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...
Diabetes device maker Beta Bionics files for $100M IPO
Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. While Beta Bionics ...
Daily3h
Automated insulin delivery decreased hypoglycemia compared with sensor-augmented pump delivery in elderly with type 1 diabetes: NEJM
A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...